Early Pacemaker Implantation after Transcatheter Aortic Valve Replacement: Impact of PlasmaBlade™ for Prevention of Device-Associated Bleeding Complications
<i>Background and Objectives</i>: Permanent pacemaker implantation (PPI) is frequently required following transcatheter aortic valve replacement (TAVR). Dual antiplatelet therapy (DAPT) or oral anticoagulation therapy (OAK) is often necessary in these patients since they are at higher ri...
Main Authors: | Alexander Lind, Majid Ahsan, Elif Kaya, Reza Wakili, Tienush Rassaf, Rolf Alexander Jánosi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/57/12/1331 |
Similar Items
-
Low-Intensity vs. High-Intensity Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Meta-Analysis of Randomized Controlled Trials
by: Tarun Chakravarty, MD, et al.
Published: (2023-03-01) -
Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy
by: Masashi Kubota, et al.
Published: (2024-03-01) -
Peri-Procedural Management of Direct-Acting Oral Anticoagulants (DOACs) in Transcatheter Miniaturized Leadless Pacemaker Implantation
by: François Diederik Regoli, et al.
Published: (2023-07-01) -
A prediction model for permanent pacemaker implantation after transcatheter aortic valve replacement
by: Yiming Qi, et al.
Published: (2023-07-01) -
Embolic Protection with the TriGuard 3 System in Nonagenarian Patients Undergoing Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis
by: Alexander Lind, et al.
Published: (2022-04-01)